Wells Fargo’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19
| Closed | -$273 | – | 7138 |
|
|
2024
Q1 | $273 | Buy |
19
+6
| +46% | +$86 | ﹤0.01% | 6032 |
|
|
2023
Q4 | $147 | Buy |
13
+1
| +8% | +$11 | ﹤0.01% | 6232 |
|
|
2023
Q3 | $178 | Buy |
12
+9
| +300% | +$133 | ﹤0.01% | 6241 |
|
|
2023
Q2 | $66 | Hold |
3
| – | – | ﹤0.01% | 6673 |
|
|
2023
Q1 | $26 | Hold |
3
| – | – | ﹤0.01% | 6984 |
|
|
2022
Q4 | $32 | Hold |
3
| – | – | ﹤0.01% | 6820 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 7263 |
|
|
2022
Q2 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 7358 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7422 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 7398 |
|